2014 -- H 8142 | |
======== | |
LC005472 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2014 | |
____________ | |
A N A C T | |
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT | |
| |
Introduced By: Representatives McNamara, Bennett, and Ruggiero | |
Date Introduced: May 01, 2014 | |
Referred To: House Health, Education & Welfare | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Sections 21-28-3.11 and 21-28-3.18 of the General Laws in Chapter 21-28 |
2 | entitled "Uniform Controlled Substances Act" are hereby amended to read as follows: |
3 | 21-28-3.11. Form, delivery, and preservation of official written orders. – (a) An |
4 | official written order for any controlled substance shall be signed in duplicate by the person |
5 | giving the order or by his or her duly authorized agent. The original shall be presented to the |
6 | person who sells or distributes the controlled substances named in it. In the event of the |
7 | acceptance of the order by that person, each party to the transaction shall preserve his or her copy |
8 | of the order for a period of two (2) years in such a way as to be readily accessible for inspection |
9 | by any public officer or employee engaged in the enforcement of this chapter. It shall be deemed |
10 | a compliance with this section if the parties to the transaction have complied with the federal law |
11 | respecting the requirements governing the use of order forms. |
12 | (b) Nothing in this section shall be construed as prohibiting the person giving the order, |
13 | or his or her duly authorized agent, from presenting said order to the person who sells or |
14 | distributes the controlled substances named in it by use of facsimile transmission. |
15 | 21-28-3.18. Prescriptions. -- (a) An apothecary in good faith may sell and dispense |
16 | controlled substances in schedule II, III, IV and V to any person upon a valid prescription by a |
17 | practitioner licensed by law to prescribe or administer those substances, dated and signed by the |
18 | person prescribing on the day when issued and bearing the full name and address of the patient to |
19 | whom, or of the owner of the animal for which, the substance is dispensed and the full name, |
| |
1 | address, and registration number under the federal law of the person prescribing, if he or she is |
2 | required by that law to be registered. If the prescription is for an animal, it shall state the species |
3 | of the animal for which the substance is prescribed. |
4 | (b) When filling a hard-copy prescription for a schedule II controlled substance, the |
5 | apothecary filling the prescription shall sign his or her full name and shall write the date of filling |
6 | on the face of the prescription. |
7 | (c) The prescription shall be retained on file by the proprietor of the pharmacy in which |
8 | it was filled for a period of two (2) years so as to be readily accessible for inspection by any |
9 | public officer or employee engaged in the enforcement of this chapter. |
10 | (d) (1) Hard copy prescriptions for controlled substances in schedule II shall be filed |
11 | separately and shall not be refilled. |
12 | (2) The director of health may shall, after appropriate notice and hearing pursuant to |
13 | section §42-35-3, promulgate rules and regulations for the purpose of adopting a system for |
14 | electronic data transmission, including by facsimile, of prescriptions for controlled substances in |
15 | schedule II, III and IV. |
16 | (3) A practitioner may sign and transmit electronic prescriptions for controlled |
17 | substances and a pharmacy may dispense an electronically transmitted prescription in accordance |
18 | with the code of federal regulations, title 21 part 1300, et seq. |
19 | (e) A prescription for a schedule II narcotic substance to be compounded for the direct |
20 | administration to a patient by parenteral, intravenous, intramuscular, subcutaneous, or intraspinal |
21 | infusion may be transmitted by the practitioner, or practitioner's agent, to the pharmacy by |
22 | facsimile. The facsimile will serve as the original prescription. |
23 | (f) A prescription for a schedule II substance for a resident of a long term care facility |
24 | may be transmitted by the practitioner or the practitioner's agent to the dispensing pharmacy by |
25 | facsimile. The facsimile serves as the original prescription. |
26 | (g) A prescription for a schedule II narcotic substance for a patient residing in a hospice |
27 | certified by Medicare under title XVIII of the Social Security Act, 42 U.S.C. section 1395 et seq., |
28 | or licensed by the state, may be transmitted by the practitioner, or practitioner's agent, to the |
29 | dispensing pharmacy by facsimile. The practitioner, or the practitioner's agent, will note on the |
30 | prescription that the patient is a hospice patient. The facsimile serves as the original, written |
31 | prescription. |
32 | (h) An apothecary, in lieu of a written prescription, may sell and dispense controlled |
33 | substances in schedules III, IV, and V to any person upon an oral prescription of a practitioner. In |
34 | issuing an oral prescription, the prescriber shall furnish the apothecary with the same information |
| LC005472 - Page 2 of 7 |
1 | as is required by subsection (a) of this section and the apothecary who fills the prescription, shall |
2 | immediately reduce the oral prescription to writing and shall inscribe the information on the |
3 | written record of the prescription made. This record shall be filed and preserved by the proprietor |
4 | of the pharmacy in which it is filled in accordance with the provisions of subsection (c) of this |
5 | section. In no case may a prescription for a controlled substance listed in schedules III, IV, or V |
6 | be filled or refilled more than six (6) months after the date on which the prescription was issued |
7 | and no prescription shall be authorized to be refilled more than five (5) times. Each refilling shall |
8 | be entered on the face or back of the prescription and note the date and amount of controlled |
9 | substance dispensed, and the initials or identity of the dispensing apothecary. |
10 | (i) In the case of an emergency situation as defined in federal law, an apothecary may |
11 | dispense a controlled substance listed in schedule II upon receiving an oral authorization of a |
12 | prescribing practitioner provided that: |
13 | (1) The quantity prescribed and dispensed is limited to the amount adequate to treat the |
14 | patient during the emergency period and dispensing beyond the emergency period must be |
15 | pursuant to a written prescription signed by the prescribing practitioner. |
16 | (2) The prescription shall be immediately reduced to writing and shall contain all the |
17 | information required in subsection (a) of this section. |
18 | (3) The prescription must be dispensed in good faith in the normal course of professional |
19 | practice. |
20 | (4) Within seven (7) days after authorizing an emergency oral prescription, the |
21 | prescribing practitioner shall cause a prescription for the emergency quantity prescribed to be |
22 | delivered to the dispensing apothecary. The prescription shall have written on its face |
23 | "Authorization for emergency dispensing" and the date of the oral order. The prescription upon |
24 | receipt by the apothecary, shall be attached to the oral emergency prescription which that had |
25 | earlier been reduced to writing. |
26 | (j) (1) The partial filling of a prescription for a controlled substance listed in schedule II |
27 | is permissible, if the apothecary is unable to supply the full quantity called for in a prescription or |
28 | emergency oral prescription and he or she makes a notation of the quantity supplied on the face of |
29 | the prescription or oral emergency prescription which that has been reduced to writing. The |
30 | remaining portion of the prescription may be filled within seventy-two (72) hours of the first |
31 | partial filling, however, if the remaining portion is not, or cannot be, filled within seventy-two |
32 | (72) hours, the apothecary shall notify the prescribing practitioner. No further quantity may be |
33 | supplied beyond seventy-two (72) hours without a new prescription. |
34 | (2) (i) A prescription for a schedule II controlled substance written for a patient in a |
| LC005472 - Page 3 of 7 |
1 | long-term-care facility (LTCF), or for a patient with a medical diagnosis documenting a terminal |
2 | illness, may be filled in partial quantities to include individual dosage units. If there is a question |
3 | whether a patient may be classified as having a terminal illness, the pharmacist must contact the |
4 | practitioner prior to partially filling the prescription. Both the pharmacist and the prescribing |
5 | practitioner have a corresponding responsibility to assure that the controlled substance is for a |
6 | terminally ill patient. |
7 | (ii) The pharmacist must record on the prescription whether the patient is "terminally ill" |
8 | or an "LTCF patient." A prescription that is partially filled, and does not contain the notation |
9 | "terminally ill" or "LTCF patient", shall be deemed to have been filled in violation of this chapter. |
10 | (iii) For each partial filling, the dispensing pharmacist shall record on the back of the |
11 | prescription (or on another appropriate record, uniformly maintained, and readily retrievable), |
12 | the: |
13 | (A) Date of the partial filling; |
14 | (B) Quantity dispensed; |
15 | (C) Remaining quantity authorized to be dispensed; and |
16 | (D) Identification of the dispensing pharmacist. |
17 | (iv) The total quantity of schedule II controlled substances dispensed in all partial fillings |
18 | must not exceed the total quantity prescribed. |
19 | (v) Schedule II prescriptions for patients in a LTCF, or patients with a medical diagnosis |
20 | documenting a terminal illness, are valid for a period not to exceed sixty (60) days from the issue |
21 | date, unless sooner terminated by the discontinuance of medication. |
22 | (k) Automated data processing systems. - As an alternative to the prescription record |
23 | keeping provision of subsection (h) of this section, an automated data processing system may be |
24 | employed for the record keeping system, if the following conditions have been met: |
25 | (1) The system shall have the capability of producing sight-readable documents of all |
26 | original and refilled prescription information. The term "sight-readable" means that an authorized |
27 | agent shall be able to examine the record and read the information. During the course of an on- |
28 | site inspection, the record may be read from the CRT, microfiche, microfilm, printout, or other |
29 | method acceptable to the director. In the case of administrative proceedings, records must be |
30 | provided in a paper printout form. |
31 | (2) The information shall include, but not be limited to, the prescription requirements |
32 | and records of dispensing as indicated in subsection (h) of this section. |
33 | (3) The individual pharmacist responsible for completeness and accuracy of the entries |
34 | to the system must provide documentation of the fact that prescription information entered into |
| LC005472 - Page 4 of 7 |
1 | the computer is correct. In documenting this information, the pharmacy shall have the option to |
2 | either: |
3 | (i) Maintain a bound log book, or separate file, in which each individual pharmacist |
4 | involved in the dispensing shall sign a statement each day, attesting to the fact that the |
5 | prescription information entered into the computer that day has been reviewed and is correct as |
6 | shown. The book or file must be maintained at the pharmacy employing that system for a period |
7 | of at least two (2) years after the date of last dispensing; or |
8 | (ii) Provide a printout of each day's prescription information. That printout shall be |
9 | verified, dated, and signed by the individual pharmacist verifying that the information indicated is |
10 | correct. The printout must be maintained at least two (2) years from the date of last dispensing. |
11 | (4) An auxiliary record keeping system shall be established for the documentation of |
12 | refills, if the automated, data-processing system is inoperative for any reason. The auxiliary |
13 | system shall ensure that all refills are authorized by the original prescription, and that the |
14 | maximum number of refills is not exceeded. When this automated data processing system is |
15 | restored to operation, the information regarding prescriptions filled and refilled during the |
16 | inoperative period, shall be entered into the automated, data processing system within ninety-six |
17 | (96) hours. |
18 | (5) Any pharmacy using an automated, data processing system must comply with all |
19 | applicable state and federal laws and regulations. |
20 | (6) A pharmacy shall make arrangements with the supplier of data processing services or |
21 | materials to ensure that the pharmacy continues to have adequate and complete prescription and |
22 | dispensing records if the relationship with the supplier terminates for any reason. A pharmacy |
23 | shall ensure continuity in the maintenance of records. |
24 | (7) The automated, data-processing system shall contain adequate safeguards for security |
25 | of the records, to maintain the confidentiality and accuracy of the prescription information. |
26 | Safeguards against unauthorized changes in data after the information has been entered and |
27 | verified by the registered pharmacist shall be provided by the system. |
28 | (l) Prescriptions for controlled substances as found in schedules II, will become void |
29 | unless dispensed within ninety (90) days of the original date of the prescription, and in no event |
30 | shall more than a thirty (30) day (30) supply be dispensed at any one time. |
31 | (1) In prescribing controlled substances in schedule II, practitioners may write up to |
32 | three (3), separate prescriptions, each for up to a one-month supply, each signed and dated on the |
33 | date written. For those prescriptions for the second and/or third month, the practitioner must write |
34 | the earliest date each of those subsequent prescription may be filled, with directions to the |
| LC005472 - Page 5 of 7 |
1 | pharmacist to fill no earlier than the date specified on the face of the prescription. |
2 | (m) The prescriptions in schedules III, IV, and V will become void unless dispensed |
3 | within one hundred eighty (180) days of the original date of the prescription. For purposes of this |
4 | section, a "dosage unit" shall be defined as a single capsule, tablet, or suppository, or not more |
5 | than one five (5) ml. of an oral liquid. |
6 | (1) Prescriptions in Schedule III cannot be written for more than one hundred (100) |
7 | dosage units and not more than one hundred (100) dosage units may be dispensed at one time. |
8 | (2) Prescriptions in Schedule IV and V may be written for up to a ninety (90) day (90) |
9 | supply based on directions. No more than three hundred and sixty (360) dosage units may be |
10 | dispensed at one time. |
11 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC005472 | |
======== | |
| LC005472 - Page 6 of 7 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT | |
*** | |
1 | This act would require, rather than permit, the director of health to promulgate rules and |
2 | regulations for the purpose of adopting a system for electronic data transmission, including by |
3 | facsimile, of prescriptions for controlled substances in schedules II, III and IV. |
4 | This act would take effect upon passage. |
======== | |
LC005472 | |
======== | |
| LC005472 - Page 7 of 7 |